plategra 60 mg
egis pharmaceuticals plc, maďarsko - tikagrelor - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
plategra 90 mg
egis pharmaceuticals plc, maďarsko - tikagrelor - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
dabahib 150 mg tvrdé kapsuly
g.l. pharma gmbh, rakúsko - dabigatránetexilát - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
dabahib 110 mg tvrdé kapsuly
g.l. pharma gmbh, rakúsko - dabigatránetexilát - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
dabahib 75 mg tvrdé kapsuly
g.l. pharma gmbh, rakúsko - dabigatránetexilát - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
lytgobi
taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - antineoplastické činidlá - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.
gribero 75 mg tvrdé kapsuly
sandoz pharmaceuticals d.d., slovinsko - dabigatran-etexilát - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
nintedanib teva 100 mg mäkké kapsuly
teva pharmaceuticals slovakia s.r.o., slovensko - nintedanib - 44 - cytostatica
nintedanib teva 150 mg mäkké kapsuly
teva pharmaceuticals slovakia s.r.o., slovensko - nintedanib - 44 - cytostatica
quviviq
idorsia pharmaceuticals deutschland gmbh - daridorexant hydrochloride - poruchy spánku a poruchy obsluhy - psycholeptika - quviviq is indicated for the treatment of adult patients with insomnia characterised by symptoms present for at least 3 months and considerable impact on daytime functioning.